|
Bosch A, Eguia J, Boix F, López M, González-Martinez G, Galian JA, Moya-Quiles MR, Llorente S, Muro M. HLA Epitopes and Shared Molecular Eplet Characterization and Their Implication on Transplant Outcome: The Experience of One Center. Clin Transpl. 2016;32:73-82. PubMed PMID: 28564524.
AÑO: 2016
|
28564524
|
López-Hernández R, Valdés M, Campillo JA, Martínez-García P, Salama H, Bolarin JM, Martínez H, Moya-Quiles MR, Minguela A, Sánchez-Torres A, Botella C, Salgado G, Miras M, Carballo F, Muro M. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease. Int J Immunogenet. 2015 Feb;42(1):38-45. doi: 10.1111/iji.12160. PubMed PMID: 25359546.
AÑO: 2015; IF: 1.174
|
|
Campillo JA, López-Hernández R, Martínez-Banaclocha H, Bolarín JM, Gimeno L, Mrowiec A, López M, Las Heras B, Minguela A, Moya-Quiles MR, Legáz I, Frías-Iniesta JF, García-Alonso AM, Álvarez-López MR, Martínez-Escribano JA, Muro M. MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain. Dis Markers. 2015;2015:831864. doi: 10.1155/2015/831864. PubMed PMID: 25838620; PubMed Central PMCID: PMC4370202.
AÑO: 2015; IF: 2.137
|
|
Muro M, Mrowiec A. Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome? Dig Dis Sci. 2015 May;60(5):1126-8. doi: 10.1007/s10620-015-3571-6. PubMed PMID: 25875754.
AÑO: 2015; IF: 2.516
|
|
Boix F, Millan O, San Segundo D, Mancebo E, Miras M, Rimola A, Fábrega E, Allende L, Minguela A, Paz-Artal E, López-Hoyos M, Brunet M, Muro M. Activated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection. Transplant Proc. 2015 Oct;47(8):2380-1. doi: 10.1016/j.transproceed.2015.09.007. PubMed PMID: 26518933.
AÑO: 2015; IF: 0.867
|